Globe Life (NYSE:GL – Get Free Report) issued an update on its FY 2024 earnings guidance on Monday morning. The company provided EPS guidance of 11.500-12.000 for the period, compared to the consensus EPS estimate of 11.600. The company issued revenue guidance of -. Globe Life also updated its FY24 guidance to $11.50-12.00 EPS.
Globe Life Stock Down 3.9 %
Shares of GL stock traded down $3.06 during mid-day trading on Thursday, hitting $75.54. 4,153,327 shares of the stock traded hands, compared to its average volume of 2,083,196. The stock has a market cap of $7.10 billion, a P/E ratio of 7.21 and a beta of 0.69. The stock’s fifty day moving average is $107.65 and its two-hundred day moving average is $115.54. Globe Life has a 52-week low of $38.95 and a 52-week high of $132.00. The company has a debt-to-equity ratio of 0.36, a current ratio of 0.05 and a quick ratio of 0.05.
Globe Life (NYSE:GL – Get Free Report) last posted its quarterly earnings data on Monday, April 22nd. The company reported $2.78 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.79 by ($0.01). Globe Life had a net margin of 18.07% and a return on equity of 23.91%. The company had revenue of $1.42 billion for the quarter, compared to analyst estimates of $1.42 billion. During the same quarter last year, the company earned $2.53 EPS. The business’s revenue was up 7.2% compared to the same quarter last year. Equities analysts predict that Globe Life will post 11.6 EPS for the current year.
Globe Life Increases Dividend
Analyst Upgrades and Downgrades
Several research firms have recently issued reports on GL. Evercore ISI cut their price objective on shares of Globe Life from $125.00 to $75.00 and set an in-line rating on the stock in a report on Friday, April 12th. Wells Fargo & Company cut their price target on shares of Globe Life from $132.00 to $108.00 and set an overweight rating on the stock in a report on Wednesday. Keefe, Bruyette & Woods upgraded shares of Globe Life from a market perform rating to an outperform rating and cut their price target for the stock from $130.00 to $110.00 in a report on Wednesday. JPMorgan Chase & Co. increased their price target on shares of Globe Life from $133.00 to $136.00 and gave the stock an overweight rating in a report on Thursday, February 8th. Finally, StockNews.com downgraded shares of Globe Life from a buy rating to a hold rating in a report on Saturday, April 20th. Five research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of Moderate Buy and an average target price of $114.33.
View Our Latest Research Report on GL
Globe Life Company Profile
Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.
See Also
- Five stocks we like better than Globe Life
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Hasbro’s Management Made All the Right Calls This Quarter
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Caterpillar’s Market Reset Isn’t Over: Get Ready for Lower Prices
- What is the Euro STOXX 50 Index?
- Power Surge: Utilities Sector’s Resilience Shines
Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.